Michele Visentin
Impact in
- Rheumatology top 5%
- Folate and B Vitamins Research
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
Papers in
- Biochemistry 10
- Amino Acid Enzymes and Metabolism 8
- Oncology 28
- Drug Transport and Resistance Mechanisms 23
- Co-authors
- I. David GoldmanRongbao ZhaoGerd A. Kullak‐UblickZhibo GaiNdeye Diop-BoveSophia L. SamodelovZhenguo WangXianjun Fu
- Journals
- Molecular Pharmacology (5 papers)International Journal of Molecular Sciences (5 papers)Drug Metabolism and Disposition (4 papers)Liver International (3 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)
- Partner nations
- SwitzerlandChinaUnited States
In The Last Decade
Michele Visentin
51 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Rheumatology 341
- Nephrology 144
- Clinical Biochemistry 137
- Biochemistry 131
- Molecular Medicine 83
Countries citing papers authored by Michele Visentin
This map shows the geographic impact of Michele Visentin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Visentin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Visentin more than expected).
Fields of papers citing papers by Michele Visentin
This network shows the impact of papers produced by Michele Visentin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Visentin. The network helps show where Michele Visentin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michele Visentin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 0 | |
| 9 | 2020 | 34 | |
| 10 | 2019 | 16 | |
| 11 | 2018 | 4 | |
| 12 | 2018 | 21 | |
| 13 | 2018 | 78 | |
| 14 | 2017 | 30 | |
| 15 | 2016 | 5 | |
| 16 | 2016 | 19 | |
| 17 | 2015 | 7 | |
| 18 | 2014 | 7 | |
| 19 | 2012 | 193 | |
| 20 | 2011 | 32 |
About Michele Visentin
Michele Visentin is a scholar working on Biochemistry, Oncology, Clinical Biochemistry, Rheumatology and Pharmacology, having authored 55 papers that have together received 1.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (23 papers), Folate and B Vitamins Research (10 papers), Amino Acid Enzymes and Metabolism (8 papers), Liver Disease Diagnosis and Treatment (7 papers), Pharmacological Effects and Toxicity Studies (7 papers), Metabolism and Genetic Disorders (6 papers), Drug-Induced Hepatotoxicity and Protection (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). The work is most often cited by research in Rheumatology (341 citations), Nephrology (144 citations), Clinical Biochemistry (137 citations), Biochemistry (131 citations) and Molecular Medicine (83 citations). Michele Visentin has collaborated with scholars based in Switzerland, China and United States. Frequent co-authors include I. David Goldman, Rongbao Zhao, Gerd A. Kullak‐Ublick, Zhibo Gai, Ndeye Diop-Bove, Sophia L. Samodelov, Zhenguo Wang, Xianjun Fu, Tianqi Wang and Christian Hiller. Their work appears in journals such as Molecular Pharmacology, International Journal of Molecular Sciences, Drug Metabolism and Disposition, Liver International and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.